A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry-Reference-Cited by-同舟云学术

A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry

Published:2017-07-17 Issue:55 Volume:8 Page:93492-93501
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Guo Qianqian¹,Chen Kai²³,Lin Xiaojie¹,Su Yi⁴,Xu Rui¹,Dai Yan¹,Qiu Chang¹,Song Xue¹,Mao Siying¹,Chen Qianjun¹

Affiliation:

1. Department of Mammary Disease, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, P.R. China

2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China

3. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China

4. Department of Intensive Care, Foshan Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of diagnostic value of artificial intelligence systems in the diagnosis of breast cancer based on histopathological images using Meta-MUMS DTA tool;Epidemiology, Biostatistics, and Public Health;2023-08-10

2. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma;BMC Cancer;2022-08-10

3. Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer;Diagnostics;2021-08-18

4. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study;Diagnostic Pathology;2019-05-04